Type 2 diabetes mellitus (T2DM) is caused by a combination of complex metabolic disorders resulting to coexisting defects in multiple organ sites.Barr, RhondaMyslinski, Mary JaneScarborough, PamelaPt Magazine of Physical TherapyBarr, R., Myslinski, M.J & Scarborough, P (2008). Understanding...
Type 2 diabetes has long been thought to have heterogenous causes, even though epidemiological studies uniformly show a tight relationship with overnutrition. The twin cycle hypothesis postulated that interaction of self-reinforcing cycles of fat accumulation inside the liver and pancreas, driven by mode...
View PDFView articleGoogle Scholar 34 N Dong, B Xu, B Wang, et al. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy Mol Vis, 4 (2013), pp. 1734-1746 Google Scholar 35 X Zhang, S Bao, D Lai, et al. Intravitreal triamcinolone acetonide...
Nonalcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease worldwide, paralleling the global epidemic of obesity and type 2 diabetes (1). In addition to the well-established metabolic and environmental risk factors, a body of evidence supports genetic predisposit...
T. et al. A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion...
Understanding Diabetes Type 2 作者: Young, Richard L. 页数: 64 ISBN: 9781481005258 豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 推荐 我来说两句 短评 ··· 热门 / 最新 / 好友 还没人写过短评呢 我要写书评 Understanding Diabetes Type 2的书评 ··· ( 全部0 条 ) 论...
To identify factors affecting adherence to medications in type 2 diabetes (T2D) care and clinical trials. Background: Adherence to medication is associated with better patient outcomes, lower healthcare costs, and improved quality and robustness of trial data. In T2D, non-adherence to regimens may...
Depression has been shown to subsequently increase the risk of, for example, cardiovascular, stroke, diabetes and obesity morbidity. These somatic consequences could partly be due to metabolic, immuno-inflammatory, autonomic and hypothalamic-pituitary-adrenal (HPA)-axis dysregulations which have been ...
三2一-c弓Co石器对二甲双胍的再认识赵志刚( 河南省人民医院内分泌科.郑州450003)【关键词】糖尿病;二甲双胍【中图分类号】R977.1+5;R587.1【文献标识码】A[文章编号11672-2809( 2008) ”一0510一02一甲双胍作为最早的口服降糖药物之一,一在糖尿病的治疗舞台上经历了50余年的风风雨雨,可以形容为“ 历久弥新...
(2006). Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat Rev Drug Discov 5: 333–342. CAS PubMed Google Scholar Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y et al. (1999). Crystal structure of the PTEN tumor suppressor: implications for its...